Researchers in the study found that the Pfizer-BioNTech shot was 88 percent effective at preventing symptomatic cases of COVID-19 resulting from the variant found in India two weeks after the second dose.
from Google Alert - health https://ift.tt/3udjuDl
via IFTTT
0 comments:
Post a Comment